T. Rowe Price Associates’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,668
| Closed | -$14K | – | 2969 |
|
|
2023
Q4 | $14K | Hold |
1,668
| – | – | ﹤0.01% | 2880 |
|
|
2023
Q3 | $8K | Buy |
1,668
+207
| +14% | +$993 | ﹤0.01% | 2867 |
|
|
2023
Q2 | $51K | Hold |
1,461
| – | – | ﹤0.01% | 2795 |
|
|
2023
Q1 | $32K | Buy |
1,461
+499
| +52% | +$10.9K | ﹤0.01% | 2825 |
|
|
2022
Q4 | $21K | Buy |
962
+132
| +16% | +$2.88K | ﹤0.01% | 2873 |
|
|
2022
Q3 | $21K | Buy |
830
+270
| +48% | +$6.83K | ﹤0.01% | 2908 |
|
|
2022
Q2 | $11K | Buy |
+560
| New | +$11K | ﹤0.01% | 2936 |
|